Bone Biologics (BBLG) Other Non Operating Income (2016 - 2018)
Bone Biologics (BBLG) reported Other Non Operating Income of -$408294.0 for Q3 2018, up 85.64% year-over-year from -$219942.7 in Q3 2017, and up 85.64% quarter-over-quarter from -$2.8 million in Q3 2017.
Bone Biologics (BBLG) Other Non Operating Income (2016 - 2018) Analysis & Trends
Bone Biologics (BBLG) has 3 years of Other Non Operating Income data on file, last reported at -$408294.0 in Q3 2018.
- Other Non Operating Income for Q3 2018 came in at -$408294.0, up 85.64% year-over-year; the trailing twelve-month figure through Dec 2018 was -$6.1 million (changed N/A YoY), and the FY2018 annual result was -$408294.0, changed N/A from the prior year.
- Other Non Operating Income grew to -$408294.0 in Q3 2018 per BBLG's latest filing, from -$2.8 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at -$4862.0 in Q1 2016 and troughed at -$2.8 million in Q2 2016.
- A 3-year average of -$2.1 million and a median of -$2.8 million in 2016 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2017 and 2018: Other Non Operating Income sank 58365.24% in 2017, then jumped 85.64% in 2018.
- A 3-year view of Other Non Operating Income shows it stood at -$2.8 million in 2016, then changed by 0.0% to -$2.8 million in 2017, then jumped by 85.64% to -$408294.0 in 2018.
- Business Quant data shows BBLG's Other Non Operating Income at -$408294.0 in Q3 2018, -$2.8 million in Q3 2017, and -$2.8 million in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -408,294.00 |
| Sep 30, 2017 | -2.84 Mn |
| Jun 30, 2017 | -2.84 Mn |
| Mar 31, 2017 | -2.84 Mn |
| Sep 30, 2016 | -2.84 Mn |
| Jun 30, 2016 | -2.84 Mn |
| Mar 31, 2016 | -4,862.00 |